Please use this identifier to cite or link to this item:
https://www.arca.fiocruz.br/handle/icict/43137
Type
ArticleCopyright
Open access
Collections
Metadata
Show full item record74
CITATIONS
74
Total citations
28
Recent citations
16
Field Citation Ratio
2.39
Relative Citation Ratio
CLINICAL AND LABORATORY DIAGNOSIS OF SARS-COV-2, THE VIRUS CAUSING COVID-19
Coronavirus disease 2019
COVID-19
Diagnostics
Imaging findings
Laboratory
Respiratory pathogens
SARS-CoV-2
Pandemic
Author
Affilliation
Fundação Oswaldo Cruz. Instituto Aggeu Magalhães. Departamento de Virologia e Terapia Experimental. Recife, PE, Brasil.
Fundação Oswaldo Cruz. Instituto Aggeu Magalhães. Departamento de Virologia e Terapia Experimental. Recife, PE, Brasil.
Fundação Oswaldo Cruz. Instituto Aggeu Magalhães. Departamento de Virologia e Terapia Experimental. Recife, PE, Brasil.
Fundação Oswaldo Cruz. Instituto Aggeu Magalhães. Departamento de Virologia e Terapia Experimental. Recife, PE, Brasil.
University of Toronto. Leslie Dan Faculty of Pharmacy. Toronto, Canada.
University of Glasgow. Institute of Infection, Immunity & Inflammation. Centre for Virus Research. Glasgow, Scotland, UK.
Fundação Oswaldo Cruz. Instituto Aggeu Magalhães. Departamento de Virologia e Terapia Experimental. Recife, PE, Brasil.
Fundação Oswaldo Cruz. Instituto Aggeu Magalhães. Departamento de Virologia e Terapia Experimental. Recife, PE, Brasil.
Fundação Oswaldo Cruz. Instituto Aggeu Magalhães. Departamento de Virologia e Terapia Experimental. Recife, PE, Brasil.
Fundação Oswaldo Cruz. Instituto Aggeu Magalhães. Departamento de Virologia e Terapia Experimental. Recife, PE, Brasil.
University of Toronto. Leslie Dan Faculty of Pharmacy. Toronto, Canada.
University of Glasgow. Institute of Infection, Immunity & Inflammation. Centre for Virus Research. Glasgow, Scotland, UK.
Fundação Oswaldo Cruz. Instituto Aggeu Magalhães. Departamento de Virologia e Terapia Experimental. Recife, PE, Brasil.
Abstract
In December 2019, a novel beta (β) coronavirus eventually named SARS-CoV-2 emerged in Wuhan, Hubei province, China, causing an outbreak of severe and even fatal pneumonia in humans. The virus has spread very rapidly to many countries across the world, resulting in the World Health Organization (WHO) to declare a pandemic on March 11, 2020. Clinically, the diagnosis of this unprecedented illness, called coronavirus disease-2019 (COVID-19), becomes difficult because it shares many symptoms with other respiratory pathogens, including influenza and parainfluenza viruses. Therefore, laboratory diagnosis is crucial for the clinical management of patients and the implementation of disease control strategies to contain SARS-CoV-2 at clinical and population level. Here, we summarize the main clinical and imaging findings of COVID-19 patients and discuss the advances, features, advantages, and limitations of different laboratory methods used for SARS-CoV-2 diagnosis.
Keywords
CoronavirusCoronavirus disease 2019
COVID-19
Diagnostics
Imaging findings
Laboratory
Respiratory pathogens
SARS-CoV-2
Pandemic
Share